NEWS
Discover recent news, press, publications & congress and industry news below.
For access to a press kit, please contact a member of the media team at info@anthostherapeutics.com.
The AZALEA-TIMI 71 Study and the Future of Factor XI Inhibition: Reflections from the American Heart Association Scientific Congress 2023
Jan 25, 2024 | PUBLICATIONS & CONGRESS
January 2024 Interviewee:Christian T. Ruff 1-5 1. Senior Investigator, Thrombolysis in Myocardial Infarction (TIMI) Study Group, Boston, Massachusetts,USA 2. Director of General Cardiology, Brigham and Women's Hospital, Boston, Massachusetts, USA 3. Associate Member,...
Addressing Suboptimal Anticoagulation in Atrial Fibrillation
Nov 17, 2023 | PUBLICATIONS & CONGRESS
Accredited CME Program MODERATOR Marc S. Sabatine, MD, MPHChairman, TIMI Study GroupLewis Dexter, MD Distinguished Chair in Cardiovascular Medicine Professor of MedicineHarvard Medical SchoolBoston, Massachusetts, United States FACULTY FACULTY Jeffrey l....
Improving the Effectiveness of Anticoagulant Therapy: The Promise of Factor XI Inhibition
Sep 15, 2023 | PUBLICATIONS & CONGRESS
This CME-accredited symposium took place on 25th June 2023, as part of the International Society for Thrombosis and Haemostasis (ISTH) Congress in Montréal, Canada Chairpeople: Shaun G. Goodman Speakers: Jean M. Connors,3-5...
ISTH 2023 Oral Presentation: Patient-Relevant Bleeding Events Among Patients Taking Anticoagulant Medication
Jun 28, 2023 | PUBLICATIONS & CONGRESS
Presenting author: Dan Bloomfield, MD Co-authors: B Alexander Yi, Karen Lipworth, Steve Burrows, Mellanie True Hills, Tarin Patrikis, Karen Pieper, Marc P. Bonaca, John Glasspool Anthos Therapeutics, Inc.; Insocius; StopAfib.org, American Foundation for Women's...
Evaluating Evolving Approaches to Treating Thrombosis in Cancer
Feb 9, 2023 | PUBLICATIONS & CONGRESS
Accredited CME Program MODERATOR Jean M. Connors, MD Medical Director, Hemostatic Antithrombotic Stewardship Medical Director, Anticoagulation Management Services (Hematology Division) Brigham and Women's Hospital/Dana-Farber Cancer Institute Associate...
Management of Thrombosis in High-Risk Patients: Focus on Cancer Associated Thrombosis
Nov 2, 2022 | PUBLICATIONS & CONGRESS
This symposium took place on 11th July 2022, as part of the International Society on Thrombosis and Haemostasis (ISTH) Congress in London, UK Chairpeople: Ajay Kakkar,1 Gary Raskob2 Speakers: Mari Thomas,3 Paula Bolton-Maggs,4,5 Giancarlo Agnelli6,7...
Factor XI Inhibition: The Holy Grail of Hemostasis‐ Sparing Anticoagulation
Dec 9, 2021 | PUBLICATIONS & CONGRESS
Factor XI Inhibition to Uncouple Thrombosis From Hemostasis – JACC 2021
Sep 3, 2021 | PUBLICATIONS & CONGRESS
Abelacimab for prevention of thromboembolism – NEJM 2021
Jul 19, 2021 | PUBLICATIONS & CONGRESS
Anthos: Solving the thrombosis dilemma with a hemostasis-sparing anticoagulant
Jul 7, 2021 | PUBLICATIONS & CONGRESS
Anthos is developing a pioneering phase 2 monoclonal antibody, abelacimab, as an effective anticoagulant that aims to provide treatment by inhibiting Factor XI to avoid severe bleeding. Thrombosis is a major unmet need. Globally more than one in four people die from...